{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:14:29Z","timestamp":1765966469674,"version":"3.48.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11427-024-2613-y","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T23:40:43Z","timestamp":1719445243000},"page":"2120-2131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Suppressor tRNA in gene therapy"],"prefix":"10.1007","volume":"67","author":[{"given":"Jingjing","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.molcel.2023.01.009","volume":"83","author":"H Adachi","year":"2023","unstructured":"Adachi, H., Pan, Y., He, X., Chen, J.L., Klein, B., Platenburg, G., Morais, P., Boutz, P., and Yu, Y.T. (2023). Targeted pseudouridylation: an approach for suppressing nonsense mutations in disease genes. Mol Cell 83, 637\u2013651.e9.","journal-title":"Mol Cell"},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1261\/rna.076042.120","volume":"26","author":"H Adachi","year":"2020","unstructured":"Adachi, H., and Yu, Y.T. (2020). Pseudouridine-mediated stop codon readthrough in S. cerevisiae is sequence context-independent. RNA 26, 1247\u20131256.","journal-title":"RNA"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.omtm.2023.05.012","volume":"29","author":"TAV Afanasyeva","year":"2023","unstructured":"Afanasyeva, T.A.V., Athanasiou, D., Perdigao, P.R.L., Whiting, K.R., Duijkers, L., Astuti, G.D.N., Bennett, J., Garanto, A., van der Spuy, J., Roepman, R., et al. (2023). CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids. Mol Ther-Methods Clin Dev 29, 522\u2013531.","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41586-023-06133-1","volume":"618","author":"S Albers","year":"2023","unstructured":"Albers, S., Allen, E.C., Bharti, N., Davyt, M., Joshi, D., Perez-Garcia, C.G., Santos, L., Mukthavaram, R., Delgado-Toscano, M.A., Molina, B., et al. (2023). Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842\u2013848.","journal-title":"Nature"},{"issue":"4","key":"2613_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1742-7843.2011.00728.x","volume":"109","author":"BH Ali","year":"2011","unstructured":"Ali, B.H., Al Z\u00e1abi, M., Blunden, G., and Nemmar, A. (2011). Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research. Basic Clin Pharmacol Toxicol 109, 4 225\u2013232.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/hmg\/ddad072","volume":"32","author":"A Amar-Schwartz","year":"2023","unstructured":"Amar-Schwartz, A., Cohen, Y., Elhaj, A., Ben-Hur, V., Siegfried, Z., Karni, R., and Dor, T. (2023). Inhibition of nonsense-mediated mRNA decay may improve stop codon read-through therapy for Duchenne muscular dystrophy. Hum Mol Genet 32, 2455\u20132463.","journal-title":"Hum Mol Genet"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03060","volume":"432","author":"N Amrani","year":"2004","unstructured":"Amrani, N., Ganesan, R., Kervestin, S., Mangus, D.A., Ghosh, S., and Jacobson, A. (2004). A faux 3\u2032-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 432, 112\u2013118.","journal-title":"Nature"},{"key":"2613_CR8","doi-asserted-by":"publisher","first-page":"105246","DOI":"10.1016\/j.jbc.2023.105246","volume":"299","author":"T Anastassiadis","year":"2023","unstructured":"Anastassiadis, T., and K\u00f6hrer, C. (2023). Ushering in the era of tRNA medicines. J Biol Chem 299, 105246","journal-title":"J Biol Chem"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A.V., Randolph, P.B., Davis, J.R., Sousa, A.A., Koblan, L.W., Levy, J.M., Chen, P.J., Wilson, C., Newby, G.A., Raguram, A., et al. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157.","journal-title":"Nature"},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJM199602013340508","volume":"334","author":"FK Askari","year":"1996","unstructured":"Askari, F.K., and McDonnell, W.M. (1996). Antisense-oligonucleotide therapy. N Engl J Med 334, 316\u2013318.","journal-title":"N Engl J Med"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1073\/pnas.0909141107","volume":"107","author":"DS Auld","year":"2010","unstructured":"Auld, D.S., Lovell, S., Thorne, N., Lea, W.A., Maloney, D.J., Shen, M., Rai, G., Battaile, K.P., Thomas, C.J., Simeonov, A., et al. (2010). Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci USA 107, 4878\u20134883.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1073\/pnas.0813345106","volume":"106","author":"DS Auld","year":"2009","unstructured":"Auld, D.S., Thorne, N., Maguire, W.F., and Inglese, J. (2009). Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci USA 106, 3585\u20133590.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0168-9452(85)90202-X","volume":"40","author":"J Barciszewski","year":"1985","unstructured":"Barciszewski, J., Barciszewska, M., Suter, B., and Kubli, E. (1985). Plant tRNA suppressors: In vivo readthrough properties and nucleotide sequence of yellow lupin seeds tRNATyr. Plant Sci 40, 193\u2013196.","journal-title":"Plant Sci"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI7866","volume":"104","author":"ER Barton-Davis","year":"1999","unstructured":"Barton-Davis, E.R., Cordier, L., Shoturma, D.I., Leland, S.E., and Sweeney, H.L. (1999). Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104, 375\u2013381.","journal-title":"J Clin Invest"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1073\/pnas.48.7.1114","volume":"48","author":"S Benzer","year":"1962","unstructured":"Benzer, S., and Champe, S.P. (1962). A change from nonsense to sense in the genetic code. Proc Natl Acad Sci USA 48, 1114\u20131121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1038\/s41467-021-27025-w","volume":"12","author":"D Bessa-Neto","year":"2021","unstructured":"Bessa-Neto, D., Beliu, G., Kuhlemann, A., Pecoraro, V., Doose, S., Retailleau, N., Chevrier, N., Perrais, D., Sauer, M., and Choquet, D. (2021). Bioorthogonal labeling of transmembrane proteins with non-canonical amino acids unveils masked epitopes in live neurons. Nat Commun 12, 6715","journal-title":"Nat Commun"},{"key":"2613_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg1878","volume":"7","author":"T Bienvenu","year":"2006","unstructured":"Bienvenu, T., and Chelly, J. (2006). Molecular genetics of Rett syndrome: When DNA methylation goes unrecognized. Nat Rev Genet 7, 415\u2013426.","journal-title":"Nat Rev Genet"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/294188a0","volume":"294","author":"M Bienz","year":"1981","unstructured":"Bienz, M., and Kubli, E. (1981). Wild-type tRNATyrG reads the TMV RNA stop codon, but Q base-modified tRNATyrQ does not. Nature 294, 188\u2013190.","journal-title":"Nature"},{"key":"2613_CR19","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1093\/nar\/8.22.5169","volume":"8","author":"M Bienz","year":"1980","unstructured":"Bienz, M., Kubli, E., J\u00fcrg, K., de Henau, S., and Grosjean, H. (1980). Nonsense suppression in eukaryotes: the use of the Xenopus oocyte as an in vivo assay system. Nucleic Acids Res 8, 5169\u20135178.","journal-title":"Nucleic Acids Res"},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41598-017-01093-9","volume":"7","author":"F Bolze","year":"2017","unstructured":"Bolze, F., Mocek, S., Zimmermann, A., and Klingenspor, M. (2017). Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes. Sci Rep 7, 1020","journal-title":"Sci Rep"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2147\/OPTH.S195564","volume":"13","author":"M Brambati","year":"2019","unstructured":"Brambati, M., Borrelli, E., Sacconi, R., Bandello, F., and Querques, G. (2019). Choroideremia: update on clinical features and emerging treatments. OPTH Volume 13, 2225\u20132231.","journal-title":"OPTH Volume"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbrc.2012.09.133","volume":"427","author":"NE Buck","year":"2012","unstructured":"Buck, N.E., Wood, L.R., Hamilton, N.J., Bennett, M.J., and Peters, H.L. (2012). Treatment of a methylmalonyl-CoA mutase stopcodon mutation. Biochem Biophys Res Commun 427, 753\u2013757.","journal-title":"Biochem Biophys Res Commun"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","volume":"190","author":"BK Burton","year":"2017","unstructured":"Burton, B.K., Charrow, J., Hoganson, G.E., Waggoner, D., Tinkle, B., Braddock, S.R., Schneider, M., Grange, D.K., Nash, C., Shryock, H., et al. (2017). Newborn screening for lysosomal storage disorders in illinois: the initial 15-month experience. J Pediatr s 190, 130\u2013135.","journal-title":"J Pediatr s"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1128\/MCB.20.9.3116-3124.2000","volume":"20","author":"M Buvoli","year":"2000","unstructured":"Buvoli, M., Buvoli, A., and Leinwand, L.A. (2000). Suppression ofnonsense mutations in cell culture and mice by multimerized suppressor tRNA genes. Mol Cell Biol 20, 3116\u20133124.","journal-title":"Mol Cell Biol"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","volume":"163","author":"J Clancy","year":"2001","unstructured":"Clancy, J., Beb\u00f6k, Z., Ruiz, F., King, C., Jones, J., Walker, L., Greer, H., Hong, J., Wing, L., Macaluso, M., et al. (2001). Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163, 1683\u20131692.","journal-title":"Am J Respir Crit Care Med"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41573-023-00829-9","volume":"23","author":"J Coller","year":"2024","unstructured":"Coller, J., and Ignatova, Z. (2024). tRNA therapeutics for genetic diseases. Nat Rev Drug Discov 23, 108\u2013125.","journal-title":"Nat Rev Drug Discov"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","volume":"13","author":"AL Collins","year":"2004","unstructured":"Collins, A.L., Levenson, J.M., Vilaythong, A.P., Richman, R., Armstrong, D.L., Noebels, J.L., David Sweatt, J., and Zoghbi, H.Y. (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13, 2679\u20132689.","journal-title":"Hum Mol Genet"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis, P.R., and Hope, M.J. (2017). Lipid nanoparticle systems for enabling gene therapies. Mol Ther 25, 1467\u20131475.","journal-title":"Mol Ther"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10020-018-0024-7","volume":"24","author":"M Dabrowski","year":"2018","unstructured":"Dabrowski, M., Bukowy-Bieryllo, Z., and Zietkiewicz, E. (2018). Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons. Mol Med 24, 25","journal-title":"Mol Med"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41587-022-01252-y","volume":"40","author":"E Dolgin","year":"2022","unstructured":"Dolgin, E. (2022). tRNA therapeutics burst onto startup scene. Nat Biotechnol 40, 283\u2013286.","journal-title":"Nat Biotechnol"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcb.22979","volume":"112","author":"PK Dranchak","year":"2011","unstructured":"Dranchak, P.K., Di Pietro, E., Snowden, A., Oesch, N., Braverman, N.E., Steinberg, S.J., and Hacia, J.G. (2011). Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cell Biochem 112, 1250\u20131258.","journal-title":"J Cell Biochem"},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1073\/pnas.0711795105","volume":"105","author":"M Du","year":"2008","unstructured":"Du, M., Liu, X., Welch, E.M., Hirawat, S., Peltz, S.W., and Bedwell, D.M. (2008). PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci USA 105, 2064\u20132069.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM199703063361005","volume":"336","author":"MJ Dunne","year":"1997","unstructured":"Dunne, M.J., Kane, C., Shepherd, R.M., Sanchez, J.A., James, R.F.L., Johnson, P.R.V., Aynsley-Green, A., Lu, S., Clement, J.P., Lindley, K.J., et al. (1997). Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336, 703\u2013706.","journal-title":"N Engl J Med"},{"key":"2613_CR34","doi-asserted-by":"publisher","first-page":"19410","DOI":"10.1073\/pnas.0706558104","volume":"104","author":"M Ejby","year":"2007","unstructured":"Ejby, M., Sorensen, M.A., and Pedersen, S. (2007). Pseudouridylation of helix 69 of 23S rRNA is necessary for an effective translation termination. Proc Natl Acad Sci USA 104, 19410\u201319415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AEH Emery","year":"1991","unstructured":"Emery, A.E.H. (1991). Population frequencies of inherited neuromuscular diseases\u2014A world survey. Neuromuscular Disord 1, 19\u201329.","journal-title":"Neuromuscular Disord"},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1073\/pnas.54.6.1791","volume":"54","author":"DL Engelhardt","year":"1965","unstructured":"Engelhardt, D.L., Webster, R.E., Wilhelm, R.C., and Zinder, N.D. (1965). In vitro studies on the mechanism of suppression of a nonsense mutation.. Proc Natl Acad Sci USA 54, 1791\u20131797.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.15302\/J-QB-022-0298","volume":"11","author":"LI Escobar","year":"2023","unstructured":"Escobar, L.I., Alonso, A.M., Ronderos, J.R., and Diambra, L. (2023). Distal nucleotides affect the rate of stop codon read-through. Quant. Biol. 11, 44","journal-title":"Quant. Biol."},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N.M., Komor, A.C., Rees, H.A., Packer, M.S., Badran, A.H., Bryson, D.I., and Liu, D.R. (2017). Programmable base editing of A-T to G-C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471.","journal-title":"Nature"},{"key":"2613_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1261\/rna.2060210","volume":"16","author":"JN Ge","year":"2010","unstructured":"Ge, J.N., Liu, H., and Yu, Y.T. (2010). Regulation of pre-mRNA splicing in Xenopus oocytes by targeted 2\u2019-O-methylation. RNA 16, 1078\u20131085.","journal-title":"RNA"},{"key":"2613_CR40","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1073\/pnas.58.5.2036","volume":"58","author":"RF Gesteland","year":"1967","unstructured":"Gesteland, R.F., Salser, W., and Bolle, A. (1967). In vitro synthesis of T4 lysozyme by suppression of amber mutations.. Proc Natl Acad Sci USA 58, 2036\u20132042.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","volume":"26","author":"MH Geurts","year":"2020","unstructured":"Geurts, M.H., de Poel, E., Amatngalim, G.D., Oka, R., Meijers, F.M., Kruisselbrink, E., van Mourik, P., Berkers, G., de Winter-de Groot, K.M., Michel, S., et al. (2020). CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid Biobank. Cell Stem Cell 26, 503\u2013510.e7.","journal-title":"Cell Stem Cell"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/nar\/26.22.5017","volume":"26","author":"R Giege","year":"1998","unstructured":"Giege, R., Sissler, M., and Florentz, C. (1998). Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res 26, 5017\u20135035.","journal-title":"Nucleic Acids Res"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/emmm.201201438","volume":"4","author":"T Goldmann","year":"2012","unstructured":"Goldmann, T., Overlack, N., M\u00f6ller, F., Belakhov, V., van Wyk, M., Baasov, T., Wolfrum, U., and Nagel-Wolfrum, K. (2012). A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol Med 4, 1186\u20131199.","journal-title":"EMBO Mol Med"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/hum.2010.067","volume":"22","author":"T Goldmann","year":"2011","unstructured":"Goldmann, T., Overlack, N., Wolfrum, U., and Nagel-Wolfrum, K. (2011). PTC124-mediated translational readthrough of a nonsense mutation causing usher syndrome type 1C. Hum Gene Ther 22, 537\u2013547.","journal-title":"Hum Gene Ther"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1750-1172-7-58","volume":"7","author":"S Gonzalez-Hilarion","year":"2012","unstructured":"Gonzalez-Hilarion, S., Beghyn, T., Jia, J., Debreuck, N., Berte, G., Mamchaoui, K., Mouly, V., Gruenert, D.C., D\u00e9prez, B., and Lejeune, F. (2012). Rescue of nonsense mutations by amlexanox in human cells. Orphanet J Rare Dis 7, 58","journal-title":"Orphanet J Rare Dis"},{"key":"2613_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20111912","volume":"443","author":"SC Harmer","year":"2012","unstructured":"Harmer, S.C., Mohal, J.S., Kemp, D., and Tinker, A. (2012). Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel. Biochem J 443, 635\u2013642.","journal-title":"Biochem J"},{"key":"2613_CR47","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1073\/pnas.84.8.2185","volume":"84","author":"YS Ho","year":"1987","unstructured":"Ho, Y.S., and Kan, Y.W. (1987). In vivo aminoacylation of human and Xenopus suppressor tRNAs constructed by site-specific mutagenesis. Proc Natl Acad Sci USA 84, 2185\u20132188.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"11226","DOI":"10.1073\/pnas.1809319115","volume":"115","author":"S Hong","year":"2018","unstructured":"Hong, S., Sunita, S., Maehigashi, T., Hoffer, E.D., Dunkle, J.A., and Dunham, C.M. (2018). Mechanism of tRNA-mediated +1 ribosomal frameshifting. Proc Natl Acad Sci USA 115, 11226\u201311231.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR49","doi-asserted-by":"publisher","first-page":"16677","DOI":"10.1074\/jbc.274.24.16677","volume":"274","author":"S Hoshino","year":"1999","unstructured":"Hoshino, S., Imai, M., Kobayashi, T., Uchida, N., and Katada, T. (1999). The eukaryotic polypeptide chain releasing factor (eRF3\/GSPT) carrying the translation termination signal to the 3\u2032-poly(a) tail of mRNA. J Biol Chem 274, 16677\u201316680.","journal-title":"J Biol Chem"},{"key":"2613_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nprot.2012.029","volume":"7","author":"C Huang","year":"2012","unstructured":"Huang, C., Wu, G., and Yu, Y.T. (2012). Inducing nonsense suppression by targeted pseudouridylation. Nat Protoc 7, 789\u2013800.","journal-title":"Nat Protoc"},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0092-8674(82)90413-5","volume":"31","author":"RM Hudziak","year":"1982","unstructured":"Hudziak, R.M., Laski, F.A., Rajbhandary, U.L., Sharp, P.A., and Capecchi, M.R. (1982). Establishment of mammalian cell lines containing multiple nonsense mutations and functional suppressor tRNA genes. Cell 31, 137\u2013146.","journal-title":"Cell"},{"key":"2613_CR52","doi-asserted-by":"crossref","unstructured":"Huth, M.E., Ricci, A.J., and Cheng, A.G. (2011). Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol: 937861.","DOI":"10.1155\/2011\/937861"},{"key":"2613_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia, N.T., Ghaemmaghami, S., Newman, J.R.S., and Weissman, J.S. (2009). Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218\u2013223.","journal-title":"Science"},{"key":"2613_CR54","doi-asserted-by":"publisher","first-page":"1253383","DOI":"10.3389\/fped.2023.1253383","volume":"11","author":"A Inserra","year":"2023","unstructured":"Inserra, A., Zarfati, A., Pardi, V., Bertocchini, A., Accinni, A., Aloi, I.P., Martucci, C., and Frediani, S. (2023). Case report: a simple and reliable approach forprogressive internal distraction of the sternum for Jeune syndrome (asphyxiating thoracic dystrophy): preliminary experience and literature review of surgical techniques. Front Pediatr 11, 1253383","journal-title":"Front Pediatr"},{"key":"2613_CR55","doi-asserted-by":"publisher","first-page":"eaax1210","DOI":"10.1126\/sciadv.aax1210","volume":"5","author":"DH Jo","year":"2019","unstructured":"Jo, D.H., Song, D.W., Cho, C.S., Kim, U.G., Lee, K.J., Lee, K., Park, S.W., Kim, D., Kim, J.H., Kim, J.S., et al. (2019). CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis. Sci Adv 5, eaax1210.","journal-title":"Sci Adv"},{"key":"2613_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10165","volume":"474","author":"J Karijolich","year":"2011","unstructured":"Karijolich, J., and Yu, Y.T. (2011). Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395\u2013398.","journal-title":"Nature"},{"key":"2613_CR57","doi-asserted-by":"crossref","unstructured":"Katrekar, D., and Mali, P. (2017). In vivo RNA targeting of point mutations via suppressor tRNAs and adenosine deaminases. bioRxiv.","DOI":"10.1101\/210278"},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41587-021-01171-4","volume":"40","author":"D Katrekar","year":"2022","unstructured":"Katrekar, D., Yen, J., Xiang, Y., Saha, A., Meluzzi, D., Savva, Y., and Mali, P. (2022). Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat Biotechnol 40, 938\u2013945.","journal-title":"Nat Biotechnol"},{"key":"2613_CR59","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","volume":"31","author":"R Kedmi","year":"2010","unstructured":"Kedmi, R., Ben-Arie, N., and Peer, D. (2010). The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials 31, 6867\u20136875.","journal-title":"Biomaterials"},{"key":"2613_CR60","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/10409238.2012.694846","volume":"47","author":"KM Keeling","year":"2012","unstructured":"Keeling, K.M., Wang, D., Conard, S.E., and Bedwell, D.M. (2012). Suppression of premature termination codons as a therapeutic approach. Crit Rev Biochem Mol Biol 47, 444\u2013463.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2613_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.jid.5700031","volume":"126","author":"R Kellermayer","year":"2006","unstructured":"Kellermayer, R., Szigeti, R., Keeling, K.M., Bedekovics, T., and Bedwell, D.M. (2006). Aminoglycosides as potential pharmacogenetic agents in the treatment of hailey-hailey disease. J Investig Dermatol 126, 229\u2013231.","journal-title":"J Investig Dermatol"},{"key":"2613_CR62","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","volume":"372","author":"E Kerem","year":"2008","unstructured":"Kerem, E., Hirawat, S., Armoni, S., Yaakov, Y., Shoseyov, D., Cohen, M., Nissim-Rafinia, M., Blau, H., Rivlin, J., Aviram, M., et al. (2008). Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: A prospective phase II trial. Lancet 372, 719\u2013727.","journal-title":"Lancet"},{"key":"2613_CR63","first-page":"43","volume":"36","author":"AV Kiselev","year":"2022","unstructured":"Kiselev, A.V., Ostapenko, O.V., Rogozhkina, E.V., Kholod, N.S., Seit Nebi, A.S., Baranov, A.N., Lesina, E.A., Ivashchenko, T.E., Sabetskii, V.A., (2022). Shavlovskii, M.M., Rechinskii, V.O., Kiselev, L.L., and Baranov, V.C. Suppression of nonsense mutations in the Dystrophin gene by a suppressor tRNA gene. Mol Biol (Mosk), 36, 43\u201347.","journal-title":"Mol Biol (Mosk)"},{"key":"2613_CR64","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0022-2836(05)80257-8","volume":"213","author":"L G Kleina","year":"1990","unstructured":"Kleina, L. G., Masson, J. M., Normanly, J., Abelson, J., and Miller, J. H. (1990). Construction of Escherichia coli amber suppressor tRNA genes. II. Synthesis of additional tRNA genes and improvement of suppressor efficiency. J Mol Biol 213, 705\u2013717.","journal-title":"J Mol Biol"},{"key":"2613_CR65","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0021-9258(17)37806-7","volume":"254","author":"J Kohli","year":"1979","unstructured":"Kohli, J., Kwong, T., Altruda, F., S\u00f6ll, D., and Wahl, G. (1979). Characterization of a UGA-suppressing serine tRNA from Schizosaccharomyces pombe with the help of a new in vitro assay system for eukaryotic suppressor tRNAs.. J Biol Chem 254, 1546\u20131551.","journal-title":"J Biol Chem"},{"key":"2613_CR66","series-title":"Dissertation for Doctoral Degree","first-page":"2807116","volume-title":"Suppressor tRNA Mediated Gene Therapy","author":"R Koukuntla","year":"2009","unstructured":"Koukuntla, R. (2009). Suppressor tRNA Mediated Gene Therapy. Dissertation for Doctoral Degree. Ames: Iowa State University, 2807116."},{"key":"2613_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jgm.2696","volume":"15","author":"R Koukuntla","year":"2013","unstructured":"Koukuntla, R., Ramsey, W.J., Young, W.B., and Link, C.J. (2013). U6 promoter-enhanced GlnUAG suppressor tRNA has higher suppression efficacy and can be stably expressed in 293 cells. J Gene Med 15, 93\u2013101.","journal-title":"J Gene Med"},{"key":"2613_CR68","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/hmg\/ddz280","volume":"29","author":"L Kuang","year":"2020","unstructured":"Kuang, L., Hashimoto, K., Huang, E.J., Gentry, M.S., and Zhu, H. (2020). Frontotemporal dementia non-sense mutation of progranulin rescued by aminoglycosides. Hum Mol Genet 29, 624\u2013634.","journal-title":"Hum Mol Genet"},{"key":"2613_CR69","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1073\/pnas.84.9.2668","volume":"84","author":"Y Kuchino","year":"1987","unstructured":"Kuchino, Y., Beier, H., Akita, N., and Nishimura, S. (1987). Natural UAG suppressor glutamine tRNA is elevated in mouse cells infected with Moloney murine leukemia virus.. Proc Natl Acad Sci USA 84, 2668\u20132672.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR70","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","volume":"20","author":"T Kurosaki","year":"2019","unstructured":"Kurosaki, T., Popp, M.W., and Maquat, L.E. (2019). Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol 20, 406\u2013420.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2613_CR71","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.ymthe.2020.03.006","volume":"28","author":"A Kwong","year":"2020","unstructured":"Kwong, A., Cogan, J., Hou, Y., Antaya, R., Hao, M., Kim, G., Lincoln, V., Chen, Q., Woodley, D.T., and Chen, M. (2020). Gentamicin induces laminin 332 and improves wound healing in junctional epidermolysis bullosa patients with nonsense mutations. Mol Ther 28, 1327\u20131338.","journal-title":"Mol Ther"},{"key":"2613_CR72","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.ymthe.2019.05.013","volume":"27","author":"C Lee","year":"2019","unstructured":"Lee, C., Hyun Jo, D., Hwang, G.H., Yu, J., Kim, J.H., Park, S., Kim, J.S., Kim, J.H., and Bae, S. (2019). CRISPR-pass: gene rescue of nonsense mutations using adenine base editors. Mol Ther 27, 1364\u20131371.","journal-title":"Mol Ther"},{"key":"2613_CR73","doi-asserted-by":"publisher","first-page":"e162809","DOI":"10.1172\/JCI162809","volume":"133","author":"G Li","year":"2023","unstructured":"Li, G., Jin, M., Li, Z., Xiao, Q., Lin, J., Yang, D., Liu, Y., Wang, X., Xie, L., Ying, W., Wang, H., Zuo, E., Shi, L., Wang, N., Chen, W., Xu, C., and Yang, H. (2023). MinidCas13X\u2013mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy. J Clin Invest 133, e162809.","journal-title":"J Clin Invest"},{"key":"2613_CR74","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1111\/1346-8138.15230","volume":"47","author":"Y Li","year":"2020","unstructured":"Li, Y., Shen, J., Liang, J., Zheng, L., Chen, F., Yao, Z., and Li, M. (2020). Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa. J Dermatol 47, e82\u2013e83.","journal-title":"J Dermatol"},{"key":"2613_CR75","doi-asserted-by":"publisher","first-page":"adv00392","DOI":"10.2340\/00015555-3760","volume":"101","author":"Y Li","year":"2021","unstructured":"Li, Y., Yu, X., Pan, C., Wang, Y., Han, J., Yao, Z., and Li, M. (2021). Effect of gentamicin ointment in patients with Nagashima-type palmoplantar keratosis: a double-blind vehicle-controlled study. Acta Derm Venereol 101, adv00392.","journal-title":"Acta Derm Venereol"},{"key":"2613_CR76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI28523","volume":"117","author":"L Linde","year":"2007","unstructured":"Linde, L., Boelz, S., Nissim-Rafinia, M., Oren, Y.S., Wilschanski, M., Yaacov, Y., Virgilis, D., Neu-Yilik, G., Kulozik, A.E., Kerem, E., etal. (2007). Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest 117, 683\u2013692.","journal-title":"J Clin Invest"},{"key":"2613_CR77","doi-asserted-by":"publisher","first-page":"107733","DOI":"10.1016\/j.ymgme.2023.107733","volume":"140","author":"P Lodewyckx","year":"2023","unstructured":"Lodewyckx, P., Issa, J., Gaschignard, M., Lamireau, D., De Lonlay, P., Servais, A., Barth, M., Courapied, S., Morin, G., Benbrik, N., et al. (2023). Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval. Mol Genet Metab 140, 107733","journal-title":"Mol Genet Metab"},{"key":"2613_CR78","doi-asserted-by":"publisher","first-page":"9449","DOI":"10.3390\/ijms21249449","volume":"21","author":"S Lombardi","year":"2020","unstructured":"Lombardi, S., Testa, M.F., Pinotti, M., and Branchini, A. (2020). Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches. Int J Mol Sci 21, 9449","journal-title":"Int J Mol Sci"},{"key":"2613_CR79","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41467-019-08329-4","volume":"10","author":"JD Lueck","year":"2019","unstructured":"Lueck, J.D., Yoon, J.S., Perales-Puchalt, A., Mackey, A.L., Infield, D.T., Behlke, M.A., Pope, M.R., Weiner, D.B., Skach, W.R., McCrayJr., P.B., et al. (2019). Engineered transfer RNAs for suppression of premature termination codons. Nat Commun 10, 822","journal-title":"Nat Commun"},{"key":"2613_CR80","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1073\/pnas.0401626101","volume":"101","author":"S Luikenhuis","year":"2004","unstructured":"Luikenhuis, S., Giacometti, E., Beard, C.F., and Jaenisch, R. (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci USA 101, 6033\u20136038.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR81","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1006\/jmbi.2000.4420","volume":"306","author":"SR Lynch","year":"2001","unstructured":"Lynch, S.R., and Puglisi, J.D. (2001). Structural origins of aminoglycoside specificity for prokaryotic ribosomes. J Mol Biol 306, 1037\u20131058.","journal-title":"J Mol Biol"},{"key":"2613_CR82","doi-asserted-by":"publisher","first-page":"12740","DOI":"10.1073\/pnas.1409436111","volume":"111","author":"T Maehigashi","year":"2014","unstructured":"Maehigashi, T., Dunkle, J.A., Miles, S.J., and Dunham, C.M. (2014). Structural insights into +1 frameshifting promoted by expanded or modification-deficient anticodon stem loops. Proc Natl Acad Sci USA 111, 12740\u201312745.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR83","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.22024","volume":"67","author":"V Malik","year":"2010","unstructured":"Malik, V., Rodino-Klapac, L.R., Viollet, L., Wall, C., King, W., Al-Dahhak, R., Lewis, S., Shilling, C.J., Kota, J., Serrano-Munuera, C., et al. (2010). Gentamicin-induced readthrough of stop codons in duchenne muscular dystrophy. Ann Neurol 67, 771\u2013780.","journal-title":"Ann Neurol"},{"key":"2613_CR84","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2217\/cer-2021-0196","volume":"11","author":"CM McDonald","year":"2022","unstructured":"McDonald, C.M., Muntoni, F., Penematsa, V., Jiang, J., Kristensen, A., Bibbiani, F., Goodwin, E., Gordish-Dressman, H., Morgenroth, L., Werner, C., et al. (2022). Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients. J Comp Eff Res 11, 139\u2013155.","journal-title":"J Comp Eff Res"},{"key":"2613_CR85","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ijms22010344","volume":"22","author":"DR McHugh","year":"2020","unstructured":"McHugh, D.R., Cotton, C.U., and Hodges, C.A. (2020). Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations. Int J Mol Sci 22, 334","journal-title":"Int J Mol Sci"},{"key":"2613_CR86","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1073\/pnas.1007336107","volume":"107","author":"DR McIlwain","year":"2010","unstructured":"McIlwain, D.R., Pan, Q., Reilly, P.T., Elia, A.J., McCracken, S., Wakeham, A.C., Itie-Youten, A., Blencowe, B.J., and Mak, T.W. (2010). Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proc Natl Acad Sci USA 107, 12186\u201312191.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/hmg\/10.2.99","volume":"10","author":"SM Medghalchi","year":"2001","unstructured":"Medghalchi, S.M. (2001). Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum Mol Genet 10, 99\u2013105.","journal-title":"Hum Mol Genet"},{"key":"2613_CR88","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/379460a0","volume":"379","author":"T Melcher","year":"1996","unstructured":"Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P.H., and Higuchi, M. (1996). A mammalian RNA editing enzyme. Nature 379, 460\u2013464.","journal-title":"Nature"},{"key":"2613_CR89","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ng1429","volume":"36","author":"JT Mendell","year":"2004","unstructured":"Mendell, J.T., Sharifi, N.A., Meyers, J.L., Martinez-Murillo, F., and Dietz, H.C. (2004). Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet 36, 1073\u20131078.","journal-title":"Nat Genet"},{"key":"2613_CR90","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/ph14080785","volume":"14","author":"S Michorowska","year":"2021","unstructured":"Michorowska, S. (2021). Ataluren\u2014promising therapeutic premature termination codon readthrough frontrunner. Pharmaceuticals 14, 785","journal-title":"Pharmaceuticals"},{"key":"2613_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cld.2018.06.001","volume":"22","author":"E Mitchell","year":"2018","unstructured":"Mitchell, E., Gilbert, M., and Loomes, K.M. (2018). Alagille syndrome. Clin Liver Dis 22, 625\u2013641.","journal-title":"Clin Liver Dis"},{"key":"2613_CR92","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort, M., Ivanov, D., Cooper, D.N., and Chuzhanova, N.A. (2008). A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat 29, 1037\u20131047.","journal-title":"Hum Mutat"},{"key":"2613_CR93","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson, C.E., Hakim, C.H., Ousterout, D.G., Thakore, P.I., Moreb, E.A., Rivera, R.M.C., Madhavan, S., Pan, X., Ran, F.A., Yan, W.X., et al. (2016). In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351, 403\u2013407.","journal-title":"Science"},{"key":"2613_CR94","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(00)80238-X","volume":"89","author":"J Ni","year":"1997","unstructured":"Ni, J., Tien, A.L., and Fournier, M.J. (1997). Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565\u2013573.","journal-title":"Cell"},{"key":"2613_CR95","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","volume":"67","author":"P Nicholson","year":"2010","unstructured":"Nicholson, P., Yepiskoposyan, H., Metze, S., Zamudio Orozco, R., Kleinschmidt, N., and M\u00fchlemann, O. (2010). Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67, 677\u2013700.","journal-title":"Cell Mol Life Sci"},{"key":"2613_CR96","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-biochem-060208-105251","volume":"79","author":"K Nishikura","year":"2010","unstructured":"Nishikura, K. (2010). Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79, 321\u2013349.","journal-title":"Annu Rev Biochem"},{"key":"2613_CR97","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nbt.3427","volume":"34","author":"TT Nomakuchi","year":"2016","unstructured":"Nomakuchi, T.T., Rigo, F., Aznarez, I., and Krainer, A.R. (2016). Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay. Nat Biotechnol 34, 164\u2013166.","journal-title":"Nat Biotechnol"},{"key":"2613_CR98","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jid.2017.10.014","volume":"138","author":"Y Ohguchi","year":"2018","unstructured":"Ohguchi, Y., Nomura, T., Suzuki, S., Takeda, M., Miyauchi, T., Mizuno, O., Shinkuma, S., Fujita, Y., Nemoto, O., Ono, K., et al. (2018). Gentamicin-induced readthrough and nonsense-mediated mRNA decay of SERPINB7 nonsense mutant transcripts. J Investig Dermatol 138, 836\u2013843.","journal-title":"J Investig Dermatol"},{"key":"2613_CR99","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1089\/10430349950017194","volume":"10","author":"RG Panchal","year":"1999","unstructured":"Panchal, R.G., Wang, S., Mcdermott, J., and Link, C.J. (1999). Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA. Hum Gene Ther 10, 2209\u20132219.","journal-title":"Hum Gene Ther"},{"key":"2613_CR100","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1212\/WNL.53.2.297","volume":"53","author":"H Papponen","year":"1999","unstructured":"Papponen, H., Toppinen, T., Baumann, P., Myllyl\u00e4, V., Leisti, J., Kuivaniemi, H., Tromp, G., and Myllyl\u00e4, R. (1999). Founder mutations and the high prevalence of myotonia congenita in northern Finland. Neurology 53, 297","journal-title":"Neurology"},{"key":"2613_CR101","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/bjd.18718","volume":"183","author":"A Peled","year":"2020","unstructured":"Peled, A., Samuelov, L., Sarig, O., Bochner, R., Malki, L., Pavlovsky, M., Pichinuk, E., Weil, M., and Sprecher, E. (2020). Treatment of hereditary hypotrichosis simplex of the scalp with topical gentamicin. Br J Dermatol 183, 114\u2013120.","journal-title":"Br J Dermatol"},{"key":"2613_CR102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","volume":"64","author":"SW Peltz","year":"2013","unstructured":"Peltz, S.W., Morsy, M., Welch, E.M., and Jacobson, A. (2013). Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med 64, 407\u2013425.","journal-title":"Annu Rev Med"},{"key":"2613_CR103","first-page":"15","volume":"22","author":"L Politano","year":"2003","unstructured":"Politano, L., Nigro, G., Nigro, V., Piluso, G., Papparella, S., Paciello, O., and Comi, L.I. (2003). Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results. Acta Myol 22, 15\u201321.","journal-title":"Preliminary results. Acta Myol"},{"key":"2613_CR104","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpedi.1997.02170400110025","volume":"151","author":"HH Pomerance","year":"1997","unstructured":"Pomerance, H.H. (1997). Nelson textbook of pediatrics. Arch Pediatr Adolesc Med 151, 324","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2613_CR105","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","volume":"30","author":"A Pupo","year":"2022","unstructured":"Pupo, A., Fern\u00e1ndez, A., Low, S.H., Fran\u00e7ois, A., Su\u00e1rez-Amar\u00e1n, L., and Samulski, R. J. (2022). AAV vectors: the Rubik\u2019s cube of human gene therapy. Mol Ther 30, 3515\u20133541.","journal-title":"Mol Ther"},{"key":"2613_CR106","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/emboj\/18.11.3133","volume":"18","author":"MI Recht","year":"1999","unstructured":"Recht, M.I. (1999). Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J 18, 3133\u20133138.","journal-title":"EMBO J"},{"key":"2613_CR107","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/newbio242230a0","volume":"242","author":"DL Riddle","year":"1973","unstructured":"Riddle, D.L., and Carbon, J. (1973). Frameshift suppression: a nucleotide addition in the anticodon of a glycine transfer RNA. Nat New Biol 242, 230\u2013234.","journal-title":"Nat New Biol"},{"key":"2613_CR108","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.abg3029","volume":"372","author":"WE Robertson","year":"2021","unstructured":"Robertson, W.E., Funke, L.F.H., de la Torre, D., Fredens, J., Elliott, T.S., Spinck, M., Christova, Y., Cervettini, D., B\u00f6ge, F.L., Liu, K.C., et al. (2021). Sense codon reassignment enables viral resistance and encoded polymer synthesis. Science 372, 1057\u20131062.","journal-title":"Science"},{"key":"2613_CR109","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.1073\/pnas.0510817103","volume":"103","author":"EA Rodriguez","year":"2006","unstructured":"Rodriguez, E.A., Lester, H.A., and Dougherty, D.A. (2006). In vivo incorporation of multiple unnatural amino acids through nonsense and frameshift suppression. Proc Natl Acad Sci USA 103, 8650\u20138655.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2613_CR110","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.ge.08.120174.001535","volume":"8","author":"JR Roth","year":"1974","unstructured":"Roth, J.R. (1974). Frameshift mutations. Annu Rev Genet 8, 319\u2013346.","journal-title":"Annu Rev Genet"},{"key":"2613_CR111","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s40265-014-0287-4","volume":"74","author":"NJ Ryan","year":"2014","unstructured":"Ryan, N.J. (2014). Ataluren: first global approval. Drugs 74, 1709\u20131714.","journal-title":"Drugs"},{"key":"2613_CR112","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"SM Ryu","year":"2018","unstructured":"Ryu, S.M., Koo, T., Kim, K., Lim, K., Baek, G., Kim, S.T., Kim, H.S., Kim, D., Lee, H., Chung, E., et al. (2018). Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol 36, 536\u2013539.","journal-title":"Nat Biotechnol"},{"key":"2613_CR113","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/humu.22047","volume":"33","author":"R S\u00e1nchez-Alcudia","year":"2012","unstructured":"S\u00e1nchez-Alcudia, R., P\u00e9rez, B., Ugarte, M., and Desviat, L.R. (2012). Feasibility of nonsense mutation readthrough as a novel therapeutical approach in propionic acidemia. Hum Mutat 33, 973\u2013980.","journal-title":"Hum Mutat"},{"key":"2613_CR114","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/s41467-022-29935-9","volume":"13","author":"EJ Sanderlin","year":"2022","unstructured":"Sanderlin, E.J., Keenan, M.M., Mense, M., Revenko, A.S., Monia, B.P., Guo, S., and Huang, L. (2022). CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway. Nat Commun 13, 2344","journal-title":"Nat Commun"},{"key":"2613_CR115","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcf.2021.05.014","volume":"21","author":"L Santos","year":"2022","unstructured":"Santos, L., Mention, K., Cavusoglu-Doran, K., Sanz, D.J., Bacalhau, M., Lopes-Pacheco, M., Harrison, P.T., and Farinha, C.M. (2022). Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation. J Cystic Fibrosis 21, 181\u2013187.","journal-title":"J Cystic Fibrosis"},{"key":"2613_CR116","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.1038\/s41467-021-27423-0","volume":"12","author":"H Sato","year":"2021","unstructured":"Sato, H., and Singer, R.H. (2021). Cellular variability of nonsense-mediated mRNA decay. Nat Commun 12, 7203","journal-title":"Nat Commun"},{"key":"2613_CR117","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","volume":"66","author":"A Schroers","year":"2006","unstructured":"Schroers, A., Kley, R.A., Stachon, A., Horvath, R., Lochm\u00fcller, H., Zange, J., and Vorgerd, M. (2006). Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency. Neurology 66, 285\u2013286.","journal-title":"Neurology"},{"key":"2613_CR118","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbagrm.2013.02.005","volume":"1829","author":"C Schweingruber","year":"2013","unstructured":"Schweingruber, C., Rufener, S.C., Z\u00fcnd, D., Yamashita, A., and M\u00fchlemann, O. (2013). Nonsense-mediated mRNA decay \u2014 mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta (BBA)-Gene Regulatory Mech 1829, 612\u2013623.","journal-title":"Biochim Biophys Acta (BBA)-Gene Regulatory Mech"},{"key":"2613_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-022-01234-1","volume":"8","author":"K She","year":"2023","unstructured":"She, K., Liu, Y., Zhao, Q., Jin, X., Yang, Y., Su, J., Li, R., Song, L., Xiao, J., Yao, S., et al. (2023). Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration. Sig Transduct Target Ther 8, 57","journal-title":"Sig Transduct Target Ther"},{"key":"2613_CR120","doi-asserted-by":"publisher","first-page":"19643","DOI":"10.1038\/s41598-022-24184-8","volume":"12","author":"A Sheriff","year":"2022","unstructured":"Sheriff, A., Guri, I., Zebrowska, P., Llopis-Hernandez, V., Brooks, I.R., Tekkela, S., Subramaniam, K., Gebrezgabher, R., Naso, G., Petrova, A., et al. (2022). ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation. Sci Rep 12, 19643","journal-title":"Sci Rep"},{"key":"2613_CR121","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41551-021-00774-1","volume":"6","author":"N Shi","year":"2022","unstructured":"Shi, N., Yang, Q., Zhang, H., Lu, J., Lin, H., Yang, X., Abulimiti, A., Cheng, J., Wang, Y., Tong, L., et al. (2022). Restoration of dystrophin expression in mice by suppressing a nonsense mutation through the incorporation of unnatural amino acids. Nat Biomed Eng 6, 195\u2013206.","journal-title":"Nat Biomed Eng"},{"key":"2613_CR122","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jb\/mvp185","volume":"147","author":"M Shiozuka","year":"2010","unstructured":"Shiozuka, M., Wagatsuma, A., Kawamoto, T., Sasaki, H., Shimada, K., Takahashi, Y., Nonomura, Y., and Matsuda, R. (2010). Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders. J Biochem 147, 463\u2013470.","journal-title":"J Biochem"},{"key":"2613_CR123","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.molcel.2022.11.011","volume":"83","author":"J Song","year":"2023","unstructured":"Song, J., Dong, L., Sun, H., Luo, N., Huang, Q., Li, K., Shen, X., Jiang, Z., Lv, Z., Peng, L., et al. (2023). CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons. Mol Cell 83, 139\u2013155.e9.","journal-title":"Mol Cell"},{"key":"2613_CR124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., and Desnick, R.J. (2006). High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79, 31\u201340.","journal-title":"Am J Hum Genet"},{"key":"2613_CR125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","volume":"5","author":"S Suh","year":"2021","unstructured":"Suh, S., Choi, E.H., Leinonen, H., Foik, A.T., Newby, G.A., Yeh, W.H., Dong, Z., Kiser, P.D., Lyon, D.C., Liu, D.R., et al. (2021). Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing. Nat Biomed Eng 5, 169\u2013178.","journal-title":"Nat Biomed Eng"},{"key":"2613_CR126","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/sj.ejhg.5200736","volume":"9","author":"C Sun","year":"2001","unstructured":"Sun, C., Tranebj\u00e6rg, L., Torbergsen, T., Holmgren, G., and Van Ghelue, M. (2001). Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 9, 903\u2013909.","journal-title":"Eur J Hum Genet"},{"key":"2613_CR127","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/nar\/gkl1071","volume":"35","author":"EE Swayze","year":"2007","unstructured":"Swayze, E.E., Siwkowski, A.M., Wancewicz, E.V., Migawa, M.T., Wyrzykiewicz, T.K., Hung, G., Monia, B.P., and Bennett, C.F. (2007). Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 35, 687\u2013700.","journal-title":"Nucleic Acids Res"},{"key":"2613_CR128","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M., Zhu, K., Cheng, J.K.W., Chew, W.L., Widrick, J.J., Yan, W.X., Maesner, C., Wu, E.Y., Xiao, R., Ran, F.A., et al. (2016). In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407\u2013411.","journal-title":"Science"},{"key":"2613_CR129","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10545-010-9265-5","volume":"34","author":"L Tan","year":"2011","unstructured":"Tan, L., Narayan, S.B., Chen, J., Meyers, G.D., and Bennett, M.J. (2011). PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation. J Inher Metab Disea 34, 443\u2013447.","journal-title":"J Inher Metab Disea"},{"key":"2613_CR130","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/296537a0","volume":"296","author":"GF Temple","year":"1982","unstructured":"Temple, G.F., Dozy, A.M., Roy, K.L., and Wai Kan, Y. (1982). Construction of a functional human suppressor tRNA gene: an approach to gene therapy for \u03b2-thalassaemia. Nature 296, 537\u2013540.","journal-title":"Nature"},{"key":"2613_CR131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","volume":"113","author":"BL Therrell Jr","year":"2014","unstructured":"TherrellJr, B.L., Lloyd-Puryear, M.A., Camp, K.M., and Mann, M.Y. (2014). Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning. Mol Genet Metab 113, 14\u201326.","journal-title":"Mol Genet Metab"},{"key":"2613_CR132","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/nar\/27.7.1683","volume":"27","author":"K Tomita","year":"1999","unstructured":"Tomita, K. (1999). The presence of pseudouridine in the anticodon alters the genetic code: A possible mechanism for assignment of the AAA lysine codon as asparagine in echinoderm mitochondria. Nucleic Acids Res 27, 1683\u20131689.","journal-title":"Nucleic Acids Res"},{"key":"2613_CR133","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.1023","volume":"49","author":"KR Wagner","year":"2001","unstructured":"Wagner, K.R., Hamed, S., Hadley, D.W., Gropman, A.L., Burstein, A.H., Escolar, D.M., Hoffman, E.P., and Fischbeck, K.H. (2001). Gentamicin treatment of Duchenneand Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49, 706\u2013711.","journal-title":"Ann Neurol"},{"key":"2613_CR134","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P.W.L., and Gao, G. (2019). Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18, 358\u2013378.","journal-title":"Nat Rev Drug Discov"},{"key":"2613_CR135","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","volume":"604","author":"J Wang","year":"2022","unstructured":"Wang, J., Zhang, Y., Mendonca, C.A., Yukselen, O., Muneeruddin, K., Ren, L., Liang, J., Zhou, C., Xie, J., Li, J., etal. (2022). AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice. Nature 604, 343\u2013348.","journal-title":"Nature"},{"key":"2613_CR136","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1101\/gad.468808","volume":"22","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt, J., Damgaard, I., Bryder, D., Theilgaard-M\u00f6nch, K., Thoren, L.A., Nielsen, F.C., Jacobsen, S.E.W., Nerlov, C., and Porse, B.T. (2008). NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev 22, 1381\u20131396.","journal-title":"Genes Dev"},{"key":"2613_CR137","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch, E.M., Barton, E.R., Zhuo, J., Tomizawa, Y., Friesen, W.J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C.R., Hwang, S., et al. (2007). PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87\u201391.","journal-title":"Nature"},{"key":"2613_CR138","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41434-022-00329-2","volume":"29","author":"H Werner","year":"2022","unstructured":"Werner, H. (2022). Toward gene therapy of Laron syndrome. Gene Ther 29, 319\u2013321.","journal-title":"Gene Ther"},{"key":"2613_CR139","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJMoa022170","volume":"349","author":"M Wilschanski","year":"2003","unstructured":"Wilschanski, M., Yahav, Y., Yaacov, Y., Blau, H., Bentur, L., Rivlin, J., Aviram, M., Bdolah-Abram, T., Bebok, Z., Shushi, L., et al. (2003). Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR Stop Mutations. N Engl J Med 349, 1433\u20131441.","journal-title":"N Engl J Med"},{"key":"2613_CR140","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1172\/JCI92707","volume":"127","author":"DT Woodley","year":"2017","unstructured":"Woodley, D.T., Cogan, J., Hou, Y., Lyu, C., Marinkovich, M.P., Keene, D., and Chen, M. (2017). Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. J Clin Invest 127, 3028\u20133038.","journal-title":"J Clin Invest"},{"key":"2613_CR141","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/emboj.2010.316","volume":"30","author":"G Wu","year":"2011","unstructured":"Wu, G., Xiao, M., Yang, C., and Yu, Y.T. (2011). U2 snRNA is inducibly pseudouridylated at novel sites by Pus7p and snR81 RNP. EMBO J 30, 79\u201389.","journal-title":"EMBO J"},{"key":"2613_CR142","doi-asserted-by":"publisher","first-page":"e2300993","DOI":"10.1002\/advs.202300993","volume":"10","author":"K Xia","year":"2023","unstructured":"Xia, K., Wang, F., Tan, Z., Zhang, S., Lai, X., Ou, W., Yang, C., Chen, H., Peng, H., Luo, P., et al. (2023). Precise correction of Lhcgr mutation in stem leydig cells by prime editing rescues hereditary primary hypogonadism in mice. Adv Sci 10, e2300993.","journal-title":"Adv Sci"},{"key":"2613_CR143","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrm2005","volume":"7","author":"J Xie","year":"2006","unstructured":"Xie, J., and Schultz, P.G. (2006). A chemical toolkit for proteins \u2014 an expanded genetic code. Nat Rev Mol Cell Biol 7, 775\u2013782.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2613_CR144","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13059-023-03086-6","volume":"24","author":"Z Yi","year":"2023","unstructured":"Yi, Z., Zhao, Y., Yi, Z., Zhang, Y., Tang, G., Zhang, X., Tang, H., Zhang, W., Zhao, Y., Xu, H., et al. (2023). Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice. Genome Biol 24, 243","journal-title":"Genome Biol"},{"key":"2613_CR145","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","volume":"72","author":"J Yuan","year":"2018","unstructured":"Yuan, J., Ma, Y., Huang, T., Chen, Y., Peng, Y., Li, B., Li, J., Zhang, Y., Song, B., Sun, X., et al. (2018). Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase. Mol Cell 72, 380\u2013394.e7.","journal-title":"Mol Cell"},{"key":"2613_CR146","doi-asserted-by":"publisher","first-page":"e1602814","DOI":"10.1126\/sciadv.1602814","volume":"3","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Long, C., Li, H., McAnally, J.R., Baskin, K.K., Shelton, J.M., Bassel-Duby, R., and Olson, E.N. (2017). CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice. Sci Adv 3, e1602814.","journal-title":"Sci Adv"},{"key":"2613_CR147","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1038\/s41467-021-27399-x","volume":"12","author":"H Zhao","year":"2021","unstructured":"Zhao, H., Ding, W., Zang, J., Yang, Y., Liu, C., Hu, L., Chen, Y., Liu, G., Fang, Y., Yuan, Y., et al. (2021). Directed-evolution of translation system for efficient unnatural amino acids incorporation and generalizable synthetic auxotroph construction. Nat Commun 12, 7039","journal-title":"Nat Commun"},{"key":"2613_CR148","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","volume":"141","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Li, Y., He, L., Pu, W., Yu, W., Li, Y., Wu, Y.T., Xu, C., Wei, Y., Ding, Q., et al. (2020). In vivo AAV-CRISPR\/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia. Circulation 141, 67\u201379.","journal-title":"Circulation"},{"key":"2613_CR149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nmeth1142","volume":"5","author":"X Zhao","year":"2008","unstructured":"Zhao, X., and Yu, Y.T. (2008). Targeted pre-mRNA modification for gene silencing and regulation. Nat Methods 5, 95\u2013100.","journal-title":"Nat Methods"},{"key":"2613_CR150","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nmeth.3478","volume":"12","author":"G Zheng","year":"2015","unstructured":"Zheng, G., Qin, Y., Clark, W.C., Dai, Q., Yi, C., He, C., Lambowitz, A.M., and Pan, T. (2015). Efficient and quantitative high-throughput tRNA sequencing. Nat Methods 12, 835\u2013837.","journal-title":"Nat Methods"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2613-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:07:20Z","timestamp":1765966040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2613-y","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"type":"print","value":"1674-7305"},{"type":"electronic","value":"1869-1889"}],"subject":[],"published":{"date-parts":[[2024,6,24]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.Z. is a scientific co-founder of VecX Biomedicines. The other author(s) declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}